Company intelligence / Profile preview

Kent Imaging

Calgary, Alberta, Canadakentimaging.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Kent Imaging’s SnapshotNIR device has received FDA clearance and Health Canada certification. It provides real-time, non-invasive tissue oxygenation imaging to support clinical decision-making in wound care, reconstructive surgery, and vascular diagnostics. The technology has been adopted across North America and internationally for improved patient outcomes in chronic wound management and surgical applications.

Therapeutic areas: OtherEndocrinologyCardiovascular
Modalities: DeviceNon-pharmacological therapy (diagnostic imaging device)Near-infrared spectroscopy-based technology
Industry: Medical Imaging

Partnerships

TVM Capital Life Science Innovation II SCSp – major investor with board representation since January 2021.

Beyond the preview

Go deeper on Kent Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kent Imaging.

Explore the full profile